Monitoring Tissue Perfusion in Critically Ill or High-risk Surgical Patients: a Pilot Clinical Study To Evaluate the aPplicability and the Safety of Urethral Perfusion Measurement With the IKORUS System
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 7
- 主要终点
- Incidence of complications
研究概览
简要总结
Circulatory shock is defined as an imbalance between oxygen supply and/or impaired oxygen use to maintain organ function. With growing evidence of lack of correlation between macro- and micro-circulation, use of "Whole Body" markers such as blood pressure (BP) or Lactates are often insufficient to assess the severity of the oxygen debt and/or tissue hypoperfusion. Thus, an approach incorporating tissue-perfusion based endpoints would represent a significant step up to guide optimal resuscitation of critically-ill patients and to reduce complications in high-risk surgery.
Current monitoring techniques, that complement systemic hemodynamics by focusing on regional perfusion, still lack the required user-friendliness and/or clinical relevance to be routinely used at bedside. Therefore, assessment of the adequacy of tissue perfusion and oxygenation is suboptimal, and implementation of the above-mentioned approaches of resuscitation is still a challenge.
Urethral perfusion is likely to be early and significantly impaired during low-flow states and thus represents a good "candidate" as a surrogate site to assess the perfusion of visceral organs. Besides, urethral mucosa can be investigated in a less invasive and simpler manner than "deeper" organs. Nowadays, no practical methods or devices are available to monitor perfusion in the pelvic area. Thus, recent development of a new monitoring device of urethral perfusion could fill this need and enable enhanced management of patients in Intensive Care Units (ICU) and Operating Rooms (OR).
The device consists of a modified Foley catheter equipped with a photoplethysmographic sensor: the IKORUS UP probe.
The probe will be used by intensivists or anesthesiologists on high-risk surgical patients, i.e. patients with comorbidities undergoing major vascular, thoracic and/or abdominal surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or more,
- •Male or female,
- •High-Risk surgical patient,
- •Life expectancy expected to exceed 72 hours,
- •Willing to participate and signed informed consent,
- •Affiliation to the French social security system.
- •Non inclusion criteria:
- •Pregnant or lactating woman,
- •History of recent urological surgery (bladder surgery, prostate surgery...),
- •Known stricture or "impossible insertion" last hospitalization,
- •Traumatic injury to the lower urinary tract,
- •History of radiotherapy of pelvic or genital area,
- •Genital malformation (Hypospadias...).
排除标准
- 未提供
研究组 & 干预措施
IKORUS UP
干预措施: IKORUS UP system (Device)
结局指标
主要结局
Incidence of complications
时间窗: 28 days
Complications rate: Injury during insertion; Bleeding; Infection; Pain; Discomfort.
次要结局
- Signal acquisition(28 days)
- Evolution of SpO2(28 days)
- Evolution of SVO2(28 days)
- Evolution of central venous pressure(28 days)
- Evolution of mean arterial pressure(28 days)
- Evolution of catecholamine infusions levels(28 days)
- Effect of the position of the sensor(28 days)
- Evolution of lactates dosages(28 days)
- Evolution of cardiac outputs(28 days)
- Applicability of the procedure(28 days)
- Quality of the signal(28 days)
- Rate of resuscitation events(28 days)
